Lepu Medical Technology Valuation Multiples

Lepu Medical Technology is valued at $3.1B as of October 2026, a 3.7x revenue multiple. In the last 12 months, Lepu Medical Technology revenue was $966M and Lepu Medical Technology EBITDA was $251M.

Lepu Medical Technology Overview

About Lepu Medical Technology

Lepu Medical Technology (Beijing) Co Ltd is a China-based company. It specializes in developing, manufacturing, and marketing high-tech medical devices and equipment. The company is engaged in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia, and critical care, in vitro diagnostics and general surgery.


Founded

2008

HQ

China

Employees

510

Financials (LTM)

Revenue: $966M
EBITDA: $251M

EV

$3.6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lepu Medical Technology Financials

Lepu Medical Technology reported last 12-month revenue of $966M and EBITDA of $251M.

In the same LTM period, Lepu Medical Technology generated $604M in gross profit, $251M in EBITDA, and $130M in net income.

Revenue (LTM)


Lepu Medical Technology P&L

In the most recent fiscal year, Lepu Medical Technology reported revenue of $970M and EBITDA of $293M.

Lepu Medical Technology is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 30%, and net margin of 15%.

See analyst estimates for Lepu Medical Technology
LTMLast FY202320242025202620272028
Revenue$966M$970M$1.2B$905M$970M
Gross Profit$604M$621M$760M$551M$621M
Gross Margin63%64%64%61%64%
EBITDA$251M$293M$332M$143M$293M
EBITDA Margin26%30%28%16%30%
EBIT Margin18%24%23%12%24%
Net Profit$130M$144M$187M$37M$144M
Net Margin14%15%16%4%15%
Net Debt-$260M---

Financial data powered by Morningstar, Inc.

Lepu Medical Technology Stock Performance

Lepu Medical Technology has current market cap of $3.1B, and enterprise value of $3.6B.

Market Cap Evolution


Lepu Medical Technology's stock price is $1.68.

Lepu Medical Technology share price decreased by 3.2% in the last 30 days, and by 34.1% in the last year.

Lepu Medical Technology has an EPS (earnings per share) of $0.08.

See more trading valuation data for Lepu Medical Technology
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3.6B$3.1B0.4%-3.2%-13.3%-34.1%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lepu Medical Technology Valuation Multiples

Lepu Medical Technology trades at 3.7x EV/Revenue multiple, and 14.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Lepu Medical Technology

EV / Revenue (LTM)


Lepu Medical Technology Financial Valuation Multiples

As of October 17, 2026, Lepu Medical Technology has market cap of $3.1B and EV of $3.6B.

Lepu Medical Technology has a P/E ratio of 23.8x.

LTMLast FY202320242025202620272028
EV/Revenue3.7x3.7x3.1x4.0x3.7x
EV/EBITDA14.4x12.3x10.9x25.2x12.3x
EV/EBIT20.4x15.7x13.2x34.0x15.7x
EV/Gross Profit6.0x5.8x4.8x6.6x5.8x
P/E23.8x21.6x16.6x84.7x21.6x
EV/FCF-27.6x167.2xn/m27.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lepu Medical Technology Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lepu Medical Technology Margins & Growth Rates

Lepu Medical Technology grew revenue by 0% but EBITDA decreased by 18% in the last fiscal year.

In the most recent fiscal year, Lepu Medical Technology reported gross margin of 64%, EBITDA margin of 30%, and net margin of 15%.

See estimated margins and future growth rates for Lepu Medical Technology

Lepu Medical Technology Margins

Last FY202420252026202720282029
Gross Margin64%61%64%62%
EBITDA Margin30%16%30%25%
EBIT Margin24%12%24%18%
Net Margin15%4%15%13%
FCF Margin13%1%13%-

Lepu Medical Technology Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth0%(24%)7%0%
Gross Profit Growth(3%)(28%)13%(3%)
EBITDA Growth(18%)(57%)105%(18%)
EBIT Growth(24%)(61%)116%(24%)
Net Profit Growth(11%)(80%)293%(11%)
FCF Growth-(48%)1063%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Lepu Medical Technology Operational KPIs

Lepu Medical Technology's revenue per employee in the last FY averaged $1.9M, while opex per employee averaged $0.8M for the same period.

Lepu Medical Technology's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lepu Medical Technology's Rule of X is 25% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Lepu Medical Technology
LTMLast FY202320242025202620272028
Rule of 4037%25%---
Bessemer Rule of X54%25%---
Revenue per Employee-$1.9M---
Opex per Employee-$0.8M---
S&M Expenses to Revenue17%9%11%12%9%
G&A Expenses to Revenue17%2%3%4%2%
R&D Expenses to Revenue12%12%11%13%12%
Opex to Revenue-40%41%49%40%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lepu Medical Technology Competitors

Lepu Medical Technology competitors include Ambu, Pulse Biosciences, Carl Zeiss Meditec, AtriCure, Imricor Medical Systems, Medacta Group, Oxford Nanopore Technologies, Autobio Diagnostics, Diagens and iRhythm Holdings.

Most Lepu Medical Technology public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ambu$906M$171M3.4x3.1x17.8x16.6x
Pulse Biosciences$350K($76M)8805.3x1822.1x(40.6x)(44.7x)
Carl Zeiss Meditec$2.5B$382M1.3x1.4x8.8x10.6x
AtriCure$535M$12M5.2x4.7x234.4x33.6x
Imricor Medical Systems$292K($26M)11510.6x1782.6x(130.9x)(126.1x)
Medacta Group$768M$220M4.1x3.7x14.1x13.5x
Oxford Nanopore Technologies$297M($132M)8.5x7.3x(19.3x)(40.0x)
Autobio Diagnostics$632M$253M4.0x3.9x10.0x10.3x

This data is available for Pro users. Sign up to see all Lepu Medical Technology competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lepu Medical Technology

When was Lepu Medical Technology founded?Lepu Medical Technology was founded in 2008.
Where is Lepu Medical Technology headquartered?Lepu Medical Technology is headquartered in China.
How many employees does Lepu Medical Technology have?As of today, Lepu Medical Technology has over 510 employees.
Is Lepu Medical Technology publicly listed?Yes, Lepu Medical Technology is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Lepu Medical Technology?Lepu Medical Technology trades under 300003 ticker.
When did Lepu Medical Technology go public?Lepu Medical Technology went public in 2009.
Who are competitors of Lepu Medical Technology?Lepu Medical Technology main competitors include Ambu, Pulse Biosciences, Carl Zeiss Meditec, AtriCure, Imricor Medical Systems, Medacta Group, Oxford Nanopore Technologies, Autobio Diagnostics, Diagens, iRhythm Holdings.
What is the current market cap of Lepu Medical Technology?Lepu Medical Technology's current market cap is $3.1B.
What is the current revenue of Lepu Medical Technology?Lepu Medical Technology's last 12 months revenue is $966M.
What is the current revenue growth of Lepu Medical Technology?Lepu Medical Technology revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Lepu Medical Technology?Current revenue multiple of Lepu Medical Technology is 3.7x.
What is the current EBITDA of Lepu Medical Technology?Lepu Medical Technology's last 12 months EBITDA is $251M.
What is Lepu Medical Technology's EBITDA margin?Lepu Medical Technology's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of Lepu Medical Technology?Current EBITDA multiple of Lepu Medical Technology is 14.4x.
How many companies Lepu Medical Technology has acquired to date?Lepu Medical Technology hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Lepu Medical Technology has invested to date?Lepu Medical Technology hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Lepu Medical Technology

Lists including Lepu Medical Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial